missing translation for 'onlineSavingsMsg'
Få mere at vide
  1. Home
  2. Products
  3. Mikrobiel identifikation testsæt
  4. C difficile test
  5. 15968012

Novacyt - Microgen Bioproducts Latex Agglutination Test: Clostridium difficile

Artikelnummer. 15968012 Shop alle Novacyt Group produkter
Klik for at se tilgængelige muligheder
Mængde:
50 Tests
Pakningsstørrelse:
50 tests
Denne vare kan ikke returneres. Se returpolicy

Artikelnummer. 15968012

Brand: Novacyt - Microgen Bioproducts M41CE

Venligst for at købe denne vare. Brug for en webkonto? Register dig hos os i dag!


 Se alternative produkter

Denne vare kan ikke returneres. Se returpolicy

Beskrivelse

Can be used to obtain rapid, presumptive-positive results from selective media for targeted identification/diagnosis.

  • From a range of available technologies for common pathogens and causatives of bowel disease.
  • Specific tests available for a variety of infection detections.
  • Rapid (2 minute), simple, sensitive, and specific latex agglutination test for the identification and confirmation of infecting colonies.
  • Can be used to obtain rapid, presumptive-positive results and provide an early indication of possible production process failure.
  • Can be used to screen colonies before full biochemical identification and can replace traditional agglutinating antibody methods.

Tekniske data

Indhold og opbevaring 2°C to 8°C
Detekterbare analytter C. difficile
Type Latex Agglutination Test
Mængde 50 Tests
Test tid 2 min.
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.